This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ausvir Therapeutics Pty Ltd. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations by Ee-Ling Seah in Medicinal Applications
Introduction
Ee-Ling Seah is a notable inventor based in Victoria, Australia. He has made significant contributions to the field of medicinal applications, particularly in the treatment and prevention of influenza. His innovative work has led to the development of a unique compound that holds promise for addressing this widespread viral infection.
Latest Patents
Ee-Ling Seah holds 1 patent for his invention titled "Compounds for medicinal applications." This patent describes compounds designed for treating and/or preventing influenza. The innovative compound consists of a first and second domain, where the first domain includes at least one anchoring group that binds to the surface of influenza viruses. The second domain comprises at least one anionic group, and these domains are covalently linked. Additionally, the patent covers pharmaceutically acceptable salts, solvates, prodrugs, or stereoisomers of the compounds.
Career Highlights
Ee-Ling Seah is currently associated with Ausvir Therapeutics Pty Ltd, where he continues to advance his research in medicinal chemistry. His work is pivotal in developing therapeutic solutions that can potentially save lives and improve public health.
Collaborations
Ee-Ling has collaborated with notable colleagues, including Betty Jin and Paul Arthur Jones. Their combined expertise contributes to the innovative environment at Ausvir Therapeutics Pty Ltd.
Conclusion
In summary, Ee-Ling Seah's contributions to medicinal applications, particularly in combating influenza, highlight his role as an influential inventor in the field. His innovative compounds and ongoing research efforts are paving the way for future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile